Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)
CAPS Rating:
A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.
RSS Headlines
Fool UK
Recs
They have a patent on a generic version of Lovenox. Last week the company was blocked by a federal appeals court from marketing their product. If their patents are upheld, their revenues will skyrocket. Lovenox is used to prevent blood clots, post surgery.